Protecting Device Innovation: An Interview With Tom Fogarty
This article was originally published in Start Up
Noted physician/entrepreneur Tom Fogarty has long been known for inventing breakthrough new products, but here he discusses his recent efforts focused on working to protect the medical device innovation model and correct what he sees as serious flaws that may hinder its long-term viability, especially in the US.
You may also be interested in...
Go to any gathering of medical device start-up CEOs and their investors, and beneath a veneer of passionate intensity about individual technology lie concern, anxiety, and in some cases, real pessimism. Central to the debate: is the device innovation model broken? Six years ago, one of the most celebrated device entrepreneurs, Tom Fogarty, MD, working with officials at El Camino Hospital in Mountain View, CA, an independent community hospital located in the heart of the San Francisco device community, launched the Fogarty Institute for Innovation, an initiative designed to help the earliest-stage companies ramp up technology development quickly and efficiently in an effort to minimize, if not eliminate the external challenges. To date, the Institute has started or nurtured five companies.
Most current cardiac diagnostic imaging tests are highly inexact, relying heavily on clinicians' observations. HeartFlow is adapting advanced computer modeling to cardiology to produce a precise, predictive, noninvasive diagnostic that doubles as a treatment planning tool. The test could eliminate unnecessary procedures for patients and save the system money, but is that what interventionalists want?
The dean of device physician-entrepreneurs is launching a new crop of start-ups. Here Thomas Fogarty, MD, a cardiovascular surgeon and the entrepreneur behind more than 30 device companies, talks about the current key issues in device company creation.